Assessing the clinical effectiveness of preventive maneuvers: Analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations A report by the Canadian task force on the periodic health examination

Journal of Clinical Epidemiology

Volumn 43, Issue 9, 1990, Pages 891-905

  Woolf, Steven H ^a   Battista, Renaldo N ^a   Anderson, Geoffrey M ^a   Logan, Alexander G ^a   Wang, Elaine ^a   Canadian Task Force on the Periodic Health Examination, ^a  

^a NONE

Author keywords

Clinical epidemiology; Effectiveness; Information synthesis; Meta analysis; Methodology; Practice guidelines; Preventive medicine; Technology assessment

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CLINICAL STUDY; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; EPIDEMIOLOGY; HUMAN; METHODOLOGY; PERIODIC MEDICAL EXAMINATION; PREVENTIVE MEDICINE; PRIORITY JOURNAL; QUALITY CONTROL; SCREENING; THEORETICAL STUDY;

EPIDEMIOLOGIC METHODS; EVALUATION STUDIES; FEMALE; HUMAN; IATROGENIC DISEASE; INFORMATION STORAGE AND RETRIEVAL; MALE; META-ANALYSIS; PREVENTIVE HEALTH SERVICES; PRIMARY PREVENTION; RESEARCH DESIGN;

EID: 0025109883     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(90)90073-X     Document Type: Article

References (90)

1. The periodic health examination
2. The periodic health examination. 1984 update
3. The periodic health examination. 1986 update
4. The periodic health examination. 1988 update
5. The periodic health examination. 1989 update
6. Approach of the Canadian Task Force to the Periodic Health Examination
7. Preventive services in clinical practice designing the periodic health examination
8. Screening for breast cancer with breast self-examination: a critical review
9. Immunizations, immunoprophylaxis, and chemoprophylaxis to prevent selected infections
10. Preventive strategies in sexually transmitted diseases for the primary care physician
11. Attributes of successful smoking cessation interventions in medical practice a meta-analysis of 39 controlled trials
12. Automobile injury: selected risk factors and prevention in the health care setting
13. Occult blood screening for colorectal cancer
14. Sigmoidoscopy in the periodic health examination
15. Physical activity counseling for healthy adults as a primary preventive intervention in the clinical setting: report for the U.S. Preventive Services Task Force
16. Preventive dentistry, I: dental caries
17. Preventive dentistry II: periodontal diseases, malocclusion, trauma, and oral cancer
18. Report of the U.S. Preventive Services Task Force
19. Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions
20. Rules of evidence and clinical recommendations on the use of antithrombotic agents
21. Scientific approach to the assessment and management of activity-related spinal disorders; a monograph for clinicians
22. Final report on the aspirin component of the ongoing Physicians' Health Study
23. Making recommendations on preventive practices: methodological issues
24. Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General
25. The epidemiology of open-angle glaucoma: a review
26. Iatrogenic perforation of the colon and rectum
27. Material serum alpha-fetoprotein screening: benefits, risks, and costs
28. Evaluation of elective repeat cesarean section as a standard care: an application of decision analysis
29. The appropriateness of carotid endarterectomy
30. Labeling of participants in high blood pressure screening programs: implications for blood cholesterol screenings
31. Labelling in hypertension: a review of the behavioral and psychological consequences
32. The morbidity of cardiac nondisease in schoolchildren
33. Evaluation of public health preschool child developmental screening: the process and outcomes of a community program
34. Parental response to repeat testing of infants with “false positive” results in a newborn screening program
35. Four-year follow-up of psychological reactions to false positive screening tests for congenital hypothyroidism
36. The medical review article: state of the science
37. A proposal for more informative abstracts of review articles
38. The retrieval of randomized clinical trials in liver disease from the medical literature a comparison of MEDLARS and manual methods
39. Guidelines for statistical reporting in articles for medical journals: amplifications and explanations
40. A method for assessing the quality of a randomized controlled trial
41. A quality assessment of randomized controlled trials of primary treatment of breast cancer
42. Reporting methods in clinical trials
43. Guidelines for reading case-control studies
44. Meta-analysis: a quantitative approach to research integration
45. Meta-analysis in medicine: where we are and where we want to go
46. Meta-analysis in clinical research
47. Problems in the medical interpretation of overviews
48. Meta-analyses of randomized controlled trials
49. Obtaining medically meaningful answers from an overview of randomized clinical trials
50. Two cheers for meta-analysis: problems and opportunities in aggregating results of clinical trials
51. The Lipid Research Clinics Coronary Primary Prevention Trial Results I Reduction in incidence of coronary heart disease
52. The Lipid Research Clinics Coronary Primary Prevention Trial Results II The relationship of reduction in incidence of coronary heart disease to cholesterol lowering
53. Helsinki Heart Study: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
54. A cooperative trial in the primary prevention of ischaemic heart disease using clofibrate
55. W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up
56. W.H.O. cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up
57. Heart panel's conclusions questioned
58. Lessons from overviews of cardiovascular trials
59. The Medical Outcomes Study: an application of methods for monitoring the results of medical care
60. An assessment of clinically useful measures of the consequences of treatment
61. Cost-effectiveness and cost-benefit analyses of vaccines
62. Consensus methods: characteristics and guidelines for use
63. The town meeting for technology: the maturation of consensus conferences
64. The consensus development program of the National Institutes of Health: current practices and historical perspectives
65. Does inappropriate use explain geographic variations in the use of health care services? A study of three procedures
66. Derivation of clinical indications for carotid endarterectomy by an expert panel
67. The appropriateness of performing coronary artery bypass surgery
68. The role of evidence in the consensus process: results from a Canadian consensus exercise
69. Consensus conferences in different countries
70. Profile of the consensus development program in Finland: the Medical Research Council of the Academy of Finland
71. Consensus development conferences in Sweden: effects on health policy and administration
72. Evaluation of the consensus conference program in Sweden: its impact on physicians
73. Profile of the consensus development program in Norway: the Norwegian Institute for Hospital Research and the National Research Council
74. Consensus development conferences in the Netherlands
75. First consensus development conference in United Kingdom: on coronary artery bypass grafting. I. Views of audience, panel, and speakers
76. First consensus development conference in United Kingdom: on coronary artery bypass grafting. II. Commentary by chairman of conference
77. The consensus process and evidence dissemination
78. Consensus or nonsensus conferences on coronary heart disease
79. Evidence and consensus
80. The two cultures of biomedicine: can there be consensus?
81. Do consensus conferences work? A process evaluation of the NIH Consensus Development Program
82. Group decision making by experts: field study of panels evaluating medical technologies
83. The NIH consensus development program: a decade later